RSS-Feed abonnieren
DOI: 10.1055/s-2005-865863
Georg Thieme Verlag KG Stuttgart · New York
Different Molecular Mechanisms Leading to White Matter Hypomyelination in Infantile Onset Lysosomal Disorders
Publikationsverlauf
Received: March 29, 2005
Accepted after Revision: June 26, 2005
Publikationsdatum:
11. August 2005 (online)

Abstract
Hypomyelinating leukoencephalopathies may be related to a primary disturbance in the formation of myelin or may be caused by neuronal, oligodendrocytic or astrocytic dysfunction, leading to a failure of myelination. Abnormal myelination related to a direct metabolic damage on oligodendrocytes has been shown to occur in some animal models of lysosomal storage diseases. To demonstrate that cerebral white matter hypomyelination may occur also in humans affected by early-onset lysosomal storage diseases, we report three cases with infantile-onset lysosomal storage disorders (type 1 GM1 gangliosidosis, globoid cell leukodystrophy or Krabbe's disease, and type A Niemann-Pick disease) showing white matter hypomyelination. Hypomyelinating leukoencephalopathy may therefore represent a feature of lysosomal storage disorders with onset in the first months of life, when the process of myelination is particularly active, indicating that neuronal storage disorders may be primarily responsible for central nervous system hypomyelination.
Key words
Lysosomal storage disorders - hypomyelination - infancy
References
- 1 Dietrich J, Lacagnina M, Gass D, Richfield E, Mayer-Proschel M, Noble M, Torres C, Proschel C. EIF2B5 mutations compromise GFAP + astrocyte generation in vanishing white matter leukodystrophy. Nat Med. 2005; 11 277-283
- 2 Folkerth R D. Abnormalities of developing white matter in lysosomal storage diseases. J Neuropathol Exp Neurol. 1999; 58 887-902
- 3 Folkerth R D, Alroy J, Bhan I, Kaye E M. Infantile GM1 gangliosidosis: complete morphology and histochemistry of two autopsy cases, with particular reference to delayed central nervous system myelination. Pediatr Dev Pathol. 2000; 3 73-86
- 4 Kaye E M, Alroy J, Raghavan S S, Schwarting G A, Adelman L S, Runge V, Gelblum D, Thalhammer J G, Zuniga G. Dysmyelinogenesis in animal model of GM1 gangliosidosis. Pediatr Neurol. 1992; 8 255-261
- 5 Percy A K, Odrezin G T, Knowles P D, Rouah E, Armstrong D D. Globoid cell leukodystrophy: comparison of neuropathology with magnetic resonance imaging. Acta Neuropathol (Berl). 1994; 88 26-32
- 6 Rodriguez-Lafrasse C, Vanier M T. Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B. Neurochem Res. 1999; 24 199-205
- 7 Suzuki K, Taniike M. Murine model of genetic demyelinating disease: the twitcher mouse. Microsc Res Tech. 1995; 32 204-214
- 8 van der Knaap M S, Breiter S N, Naidu S, Hart A A, Valk J. Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology. 1999; 213 121-133
- 9 van der Knaap M S. Magnetic resonance in childhood white matter disorders. Dev Med Child Neurol. 2001; 43 705-712
- 10 van der Voorn J P, Kamphorst W, van der Knaap M S, Powers J M. The leukoencephalopathy of infantile GM1 gangliosidosis: oligodendrocytic loss and axonal dysfunction. Acta Neuropathol (Berl). 2004; 107 539-545
MD Roberta Biancheri
Neuromuscular Disease Unit
Istituto G. Gaslini
Largo G. Gaslini, 5
16147 Genova
Italy
eMail: roberta@biancheri.com